PRAX Praxis Precision Medicines, Inc. Soliqdan keyingi foyda

praxismedicines.com (PRAX) korporativ emblemasi va logotipi

Praxis Precision Medicines (PRAX) kompaniyasining narxlar tarixi hozirda -0.34 darajasida bo'lgan foyda dinamikasini aks ettiradi. Biznes o'zining maxsus neyromeditsina ishlanmalariga tayanadi va mahsulotlarini bozorga chiqarish uchun yirik ittifoqchi qidirmoqda. Tajribali rahbariyat jamoani boshqarib, investitsiyalarni mahorat bilan jalb qilmoqda va tadqiqotlarni nazorat qilmoqda. Biroq, kompaniya potensial sinovlar muvaffaqiyatsizligi sababli sanoat yetakchilari bilan bo'lgan shiddatli kurashda mag'lub bo'lish xavfi ostida qolmoqda.

PRAX (Praxis Medicines) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

Praxis Precision Medicines, Inc. (PRAX) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Praxis Corp|PRAX - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Praxis Corp|PRAX - Kompaniyaning to‘liq qiymati
- emitentning balans qiymati statistikasi:
Aksiyaning buxgalteriya qiymati Praxis Precision Medicines|PRAX - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati praxismedicines.com|PRAX - Kompaniyaning yakuniy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning xususiy kapitalga nisbati Praxis Precision Medicines|PRAX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Praxis Precision Medicines Inc|PRAX - Kompaniya qarzlari|Sof aktivlarga qarzlar Praxis Corp|PRAX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Praxis Precision Medicines|Kritik likvidlik koeffitsiyenti praxismedicines.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PRAX - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:PRAX - Praxis Corp
Praxis Medicines brendining mahsuloti

Praxis Precision Medicines (PRAX) hozirda tijorat imkoniyatlariga ega bo'lmagan holda, epilepsiyaga qarshi dori vositalarini tadqiq qilish va ishlab chiqish (R&D) yo'nalishiga katta resurslar investitsiya qilmoqda. Kompaniyaning haqiqiy foydasini tahlil qilish choraklik hisobotlar bilan bog'liq vaqt kechikishlarini bartaraf etgan holda, kunlik sof daromad dinamikasini kuzatish imkonini beradi. Ushbu ko'rsatkich joriy qiymatlarni o'rtacha ko'rsatkichlar bilan solishtirish orqali operatsion kuchning to'planishini yoki pozitsiyaning yo'qotilishini aniqlaydi. Indikatorning median qiymatdan yuqori barqarorligi kapital uchun himoya to'sig'ini yaratib, emitentning ishlab chiqish bosqichidagi moliyaviy barqarorligini tasdiqlaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD (ACADIA Pharma) - Yakuniy foyda|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Sof foyda Viking Therapeutics Corp VKTX|SUPN: Sof daromad|CPRX (catalystpharma.com) - Kompaniya foydasi|DNLI: Sof foyda|HRMY - Sof moliyaviy natija|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Amylyx Corp (AMLX) - Sof moliyaviy natija|Sof daromad TRVI (Trevi Therapeutics)|AVXL (anavex.com) - Yakuniy foyda|Kompaniyaning sof foydasi CeriBell CBLL|PRTA (Prothena Corp) - Soliqdan keyingi foyda|ALEC - Kompaniyaning sof foydasi|Yakuniy foyda ANNX (Annexon Biosciences Inc.)|OMER: Sof foyda|Kompaniyaning sof daromadi neurogene.com (NGNE)|ACIU (AC Immune SA) - Sof foyda|Sof daromad Voyager Therapeutics Inc (VYGR)|Sof foyda NMRA|Sof moliyaviy natija Scilex Holding Company, Inc.|Kompaniyaning sof foydasi Tevogen Bio Holdings TVGN|Sof moliyaviy natija Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Sof foyda|Sof moliyaviy natija Inhibikase Therapeutics Inc IKT|Cassava (SAVA) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Assertio (ASRT)|Kompaniyaning sof foydasi Coya Therapeutics Inc|Kompaniya foydasi VTGN (VistaGen Therapeutics Inc)|Sof daromad OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi CervoMed Inc CRVO|ATHE - Sof daromad|Clene Nanomedicine - Sof foyda|Kompaniyaning sof daromadi PepGen Inc.|JUNS: Sof foyda|Kompaniya foydasi RLMD|ANVS (Annovis Bio Corp) - Sof foyda|Grace Tx (GRCE) - Sof moliyaviy natija|Sof foyda AIFF|Sof daromad anewmeds.com KLTO|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof moliyaviy natija Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Sof moliyaviy natija|Kompaniyaning sof foydasi Athira (ATHA)|ADXN: Soliqdan keyingi foyda|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Yakuniy foyda CYCN|Protagenic - Sof foyda|KTTA - Sof foyda|CRGT (cortigent.com) - Sof daromad|Kompaniya foydasi ATXI|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniya foydasi CARA (caratherapeutics.com)|Sof foyda CHRO|ELYM - Kompaniyaning sof daromadi|Intra-Cellular Therapies, Inc. - Sof daromad|Sof foyda Longboard LBPH|MRNS - Kompaniyaning sof foydasi|Yakuniy foyda NKGN (nkgenbiotech.com)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Sage Therapeutics Inc. (SAGE)|Kompaniyaning sof foydasi Neurotrope|Trevena Inc - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)